|
|
 |
International Clinical Trials in Nephrology/Urology
Argentina
Australia
Austria
Belgium
Brazil
Bulgaria
Canada
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
Barrie; The Male/Female Health and Research Centre - Royal Court Medical Centre
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
Greenfield Park; Urology South Shore Research
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
Kelowna, BC; Southern Interior Medical Research Inc.
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
Kingston, Ontario; Centre for Advanced Urological Research
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
Kitchener; Urologic Associates
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
Montreal; CHUM Hopital St Luc
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
North Bay, Ontario; Canada Place Building
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
Oakville; The Fe/Male Health Centers
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
Pointe Claire; Research Center
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
Quebec; Research Center
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
Surrey, BC; Andreou Research
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
Toronto; The Male Health Center
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
Toronto, Ontario; University Health Network Princess Margaret Hospital
- Benign Prostatic Hyperplasia (Enlarged Prostate): A study with an experimental drug given each 6 months to help improve difficulty urinating due to an enlarged prostate
Victoria, BC; Can-Med Clinical Research Inc.
- Bladder Cancer: The main purpose of this research study is to evaluate the safety and dosing of an investigational gene transfer agent called CG0070 and to see if it has an effect on superficial bladder cancer that does not respond to prior BCG (bacillus Calmette-Guerin) treatment.
Barrie, ON; Male/Female Health and Research Centre
- Bladder Cancer: The main purpose of this research study is to evaluate the safety and dosing of an investigational gene transfer agent called CG0070 and to see if it has an effect on superficial bladder cancer that does not respond to prior BCG (bacillus Calmette-Guerin) treatment.
Various Cities; The Female Male Health Center
- Bladder Disorders: A research study for patients with symptoms of overactive
bladder.
Victoria, BC; Dr. Steinhoff Clinical Research
- Bladder Disorders: A research study for patients with symptoms of overactive
bladder.
Victoria, BC; Can-Med Clinical Research Inc.
- Kidney Transplantation: A Study of the Effect of CellCept (Mycophenolate Mofetil) on Renal Function After Withdrawal of Cyclosporine in Kidney Transplant Patients
Toronto, ON; Research Site:
- Kidney Transplantation: A Study of the Effect of CellCept (Mycophenolate Mofetil) on Renal Function After Withdrawal of Cyclosporine in Kidney Transplant Patients
Vancouver, BC; Research Site:
- Kidney Transplantation: A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients
Calgary, AB; Research Site:
- Kidney Transplantation: A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients
Edmonton, AB; Research Site:
- Kidney Transplantation: A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients
Saskatoon, SK; Research Site:
- Kidney Transplantation: A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients
Vancouver, BC; Research Site:
- Kidney Transplantation: CLEAR study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants
Edmonton, AB; Research Site:
- Kidney Transplantation: CLEAR study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants
Halifax, NS; Research Site:
- Kidney Transplantation: CLEAR study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants
Montreal, QC; Research Site:
- Kidney Transplantation: CLEAR study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants
Quebec City, QC; Research Site:
- Kidney Transplantation: CLEAR study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants
Saskatoon, SK; Research Site:
- Kidney Transplantation: CLEAR study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants
Toronto, ON; Research Site:
- Kidney Transplantation: CLEAR study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants
Vancouver, BC; Research Site:
- Liver Transplantation: A Study of CellCept (Mycophenolate Mofetil) in Liver Transplant Patients
London, ON; Research Site:
- Liver Transplantation: Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant
Edmonton, AB; Research Site:
- Liver Transplantation: Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant
Halifax, NS; Research Site:
- Liver Transplantation: Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant
London, ON; Research Site:
- Liver Transplantation: Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant
Montreal, QC; Research Site:
- Prostate Cancer: VITAL-1 GVAX® Prostate Cancer Immunotherapy Trial (G-0029)
Montreal, Quebec; Centre Hospitalier de l'Universite de Montreal
- Prostate Cancer: VITAL-1 GVAX® Prostate Cancer Immunotherapy Trial (G-0029)
Montreal, Quebec; McGill University
- Prostate Cancer: VITAL-1 GVAX® Prostate Cancer Immunotherapy Trial (G-0029)
Toronto, Ontario; Princess Margaret Hospital
- Prostate Cancer: VITAL-2 GVAX ® Immunotherapy for Prostate Cancer Trial (G-0034)
Calgary, Alberta; Tom Baker Cancer Centre
- Prostate Cancer: VITAL-2 GVAX ® Immunotherapy for Prostate Cancer Trial (G-0034)
Montreal, Quebec; Centre Hospitalier de L'Universite de Montreal
- Prostate Cancer: VITAL-2 GVAX ® Immunotherapy for Prostate Cancer Trial (G-0034)
Sherbrooke, Quebec; Centre Hospitalier Universite de Sherbrooke
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
Kitchener, ON; Research Site:
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
Toronto, ON; Research Site:
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
London, ON; Research Site:
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
Montreal, QC; Research Site:
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
Sherbrooke, QC; Research Site:
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
Toronto, ON; Research Site:
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
Vancouver, BC; Research Site:
- Urinary Incontinence: A research study for patients with symptoms of overactive
bladder.
Victoria, BC; Can-Med Clinical Research Inc.
- Urinary Incontinence: A research study for patients with symptoms of overactive
bladder.
Victoria, BC; Dr. Steinhoff Clinical Research
Chile
China
Colombia
Costa Rica
Czech Republic
Finland
France
Germany
Hong Kong
Hungary
Indonesia
Italy
Korea
Kuala Lumpur
Malaysia
Mexico
Negeri Sembilan
Netherlands
Norway
Peru
Philippines
Poland
Portugal
Quebec
Republic of Korea
Romania
Russian Federation
Singapore
South Africa
Spain
Sweden
Switzerland
Taiwan
Thailand
United Kingdom
|
|
Back to CWWorld
|
This site is run by CenterWatch, a publishing company that focuses
on the clinical trials industry. The information provided in this
service is designed to help patients find clinical trials that may
be of interest to them, and to help patients contact the centers conducting
the research. CenterWatch is neither promoting this research nor involved
in conducting any of these trials.
Trial listings updated: May 8, 2008 at 2:58:25 PM
Copyright © 1995 - 2008, CenterWatch
All Rights Reserved
This site was developed in association with Illumina Interactive, Boston, MA
|
|
